You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gemcis

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis Trial in Tianjin (Durvalumab, Surgery, Gemcitabine)

Recruiting
  • Durvalumab
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jan 3, 2023

Bile Duct Cancer Trial in France (GEMCIS, mFolfirinox)

Completed
  • Bile Duct Cancer
  • Amiens, France
  • +41 more
Feb 23, 2022

Gallbladder Cancer Trial in New Delhi (Gemcitabine + Cisplatin)

Completed
  • Gallbladder Cancer
  • Gemcitabine + Cisplatin
  • New Delhi, India
    GIPMER
Apr 2, 2021

Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Jun 8, 2022

Advanced Biliary Tract Carcinoma Trial in France (Durvalumab, Tremelimumab)

Recruiting
  • Advanced Biliary Tract Carcinoma
  • Besançon, France
  • +27 more
Jan 26, 2021

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Urinary Bladder Cancer Trial in Germany (GemCis + Panitumumab, GemCis)

Terminated
  • Urinary Bladder Cancer
  • GemCis + Panitumumab
  • GemCis
  • Berlin, Germany
  • +19 more
Jun 2, 2015

Small Cell Lung Cancer Trial in Italy (gemcitabine, vinorelbine, cisplatin)

Completed
  • Small Cell Lung Cancer
  • Monteforte Irpino, AV, Italy
  • +20 more
Jan 13, 2016

Lung Cancer Trial in Goyang-si (gemcitabine, Oxaliplatin, Cisplatin)

Unknown status
  • Lung Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center, Korea
Oct 22, 2010